Rendering

Component: (Network and Table)
Network
100450 - Disclosure - Income Taxes - Reconciliation of Income Taxes to Amount Computed by Applying Statutory Federal Income Tax Rate to Net Loss (Detail)
(http://www.acadia-pharm.com/20161231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxesToAmountComputedByApplyingStatutoryFederalIncomeTaxRateToNetLossDetail)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001070494 (http://www.sec.gov/CIK)
Income Tax Disclosure [Abstract]Period [Axis]
2016-01-01 - 2016-12-31
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
Income Tax Disclosure [Abstract]
 
 
 
Amounts computed at statutory federal rate
(91,818,000) 
(55,799,000) 
(31,441,000) 
Stock-based compensation and other permanent differences
3,065,000  
1,752,000  
1,417,000  
R&D credits
(3,390,000) 
(3,782,000) 
(2,420,000) 
Change in valuation allowance
27,583,000  
4,580,000  
37,106,000  
State taxes
272,000  
742,000  
(5,092,000) 
Contingencies
361,000  
2,247,000  
 
Foreign rate differential
64,065,000  
48,456,000  
4,000  
Other
1,203,000  
2,134,000  
426,000  
Income tax expense
1,341,000  
 
330,000